Navigation Links
Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays
Date:5/14/2013

7DIAMOND DIAGNOSTICS INC. 58DIASOURCE IMMUNOASSAYS S.A. 58IBL INTERNATIONAL GMBH 59IMMUNOCHEMISTRY TECHNOLOGIES LLC 60HISTORY 60PRODUCTS, SERVICES, AND RESEARCH 60IMMUNOSHOP INDIA PVT LTD. 61INSTITUTE OF ISOTOPES CO. LTD 61INSTRUMENTATION LABORATORY CO. 62NOVARTIS VACCINES & DIAGNOSTICS INC. 62JEI DANIEL BIOTECH CORP. 63LABOR DIAGNOSTIKA NORD GMBH & CO. KG 63MICROPOINT BIOSCIENCE INC. 64ORTHO CLINICAL DIAGNOSTICS 65PANTEX 65PROMEGA CORP. 65QQLAB LLC 66QUIDEL CORP. 66RADIOMETER GMBH 68ROCHE DIAGNOSTICS CORP. 69SIEMENS HEALTHCARE 69SYSMEX 69TRINITY BIOTECH PLC 70WEIFANG 3V BIOENGINEERING GROUP CO. LTD. 71WEIFANG KANGHUA BIOTECH CO. LTD. 71XIAMEN BOSON BIOTECH CO. LTD. 72ZHEJIANG ZHUJI BETAI BIOTECHNOLOGY CO. LTD. 73

CHAPTER 8 PATENT ANALYSIS 75

INTRODUCTION 75GLOBAL PATENT TRENDS 75TABLE 30 GLOBAL PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OFPATENTS/%) 75TABLE 31 GLOBAL PATENT SHARES BY ASSIGNEE 76U.S. PATENT TRENDS 80TABLE 32 U.S. PATENT GENERATION TRENDS BY YEARS, 2000-2012 (NO. OFPATENTS/%) 80TABLE 33 U.S. PATENT SHARES BY TECHNOLOGY, 2000-2012 81U.S. PATENT SHARES BY ASSIGNEE 81TABLE 34 U .S. PATENT SHARES BY ASSIGNEE 2000-2012 81SAMPLE ABSTRACTS OF U.S. PATENT ABSTRACTS 82AUTOANTIBODY-ENHANCED IMMUNOASSAYS AND KITS 82FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIALTOXIN ACTIVITY 82CHEMILUMINESCENT COMPOSITIONS FOR USE IN DETECTION OF MULTIPLEANALYTES 83U.S. REGISTERED PATENTS 83TABLE 35 SAMPLE OF U.S. IMMUNOASSAY PATENTS, 2000-2012 84EUROPEAN PATENT TRENDS 84TABLE 36 EUROPEAN PATENT GENERATION TRENDS BY YEARS, 2000-2012 (NO. OFPATENTS/%) 84TABLE 37 EUROPEAN PATENT SHARES BY TECHNOLOGY, 2000-2012 85EUROPEAN PATENT SHARES BY PATENT HOLDER 85TABLE 38 EUROPEAN PATENT SHARES BY APPLICATION, 2000-2012 86SAMPLE ABSTRACTS OF EUROPEAN PATENT ABSTRACTS 87IMMUNOASSAY PRODUCT AND PROCESS 87ENZYME IMMUNOASSAY MEMBRANE STRIP WITH CRITICAL VALUE LINEAND INTERPRETATION METHOD THEREOF 88FLUORESCENCE IMMUNOASSAY ME
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
2. AG Mednet CEO Abraham Gutman to Moderate Disruptive Technologies Session at CenterWatch Forum on Optimizing Clinical Research Performance
3. Patient Safety Technologies Reports First Quarter 2013 Results
4. Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers
5. BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2013 Financial Results on Friday, May 10, 2013
6. Blue Belt Technologies kündigt Gründung eines wissenschaftlichen Beirats für Hüfteingriffe zur Bestimmung neuer Anwendungsgebiete von NavioPFS bei femoro-acetabulärem Impingement an
7. Blue Belt Technologies maakt vorming van Wetenschappelijke Heup Adviesraad bekend voor ontwikkeling van volgende NavioPFS-toepassing voor femoroacetabulair impingement
8. Blue Belt Technologies Announces Formation of Hip Scientific Advisory Board for Development of Next NavioPFS Application for Femoroacetabular Impingement
9. Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus
10. Update to Shareholders on Dividend Payment: Medisafe 1 Technologies Corporation Files Corporate Action Form with FINRA for the Dividend Distribution to its Shareholders
11. Flexpoint Announces Universal Settlement Involving the Medical Bed and Related Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Intarcia Therapeutics, Inc. today announced successful top-line results ... for ITCA 650 (exenatide, delivered continuously once or twice ... trial, FREEDOM-1, was a placebo-controlled, double-blind phase 3 clinical ... 650 in patients with type 2 diabetes against placebo. ... to placebo for both 40 mcg and 60 mcg ...
(Date:10/1/2014)... , Oct. 1, 2014 ... now available. Interested parties can learn about ... Cardinal Health is supporting the health care ... http://cardinalhealth.com/annualreport . Photo- http://photos.prnewswire.com/prnh/20140930/149504-INFO ... summary financials and the chief executive officer,s ...
(Date:10/1/2014)...  Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a ... used to develop and produce enzymes and other ... industrial enzymes industries, today announced the receipt of ... commercial scale production of Abengoa,s proprietary cellulase enzymes, ... Abengoa,s license agreement with Dyadic. ...
Breaking Medicine Technology:Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 2Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 3Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 4Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 5Cardinal Health 2014 Digital Report to Shareholders Now Available 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 3
... Ltd. (NYSE Amex: CPD ) announced that ... (Sun) have been extended until January 28, 2012 but ... which was originally set to expire in January 2010, ... and is being extended for an additional 1 year ...
... Pharmaceutical Company (NYSE: KVa/KVb) today announced the filing of its ... with the Securities and Exchange Commission.  As a result, the ... 2010 Form 10-K to enable its securities to continue trading ... is currently working on preparing and filing its quarterly reports ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma 2Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma 3K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 2K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 3K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 4K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 5K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 6K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 7K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 8
(Date:10/1/2014)... from the University of Adelaide have developed a model ... a good outcome from treatment - from their very ... a range of factors, including clinical symptoms, cognitive abilities, ... the patient,s blood. , Speaking in the lead up ... Head of Psychiatry , Professor Bernhard Baune ...
(Date:10/1/2014)... research co-funded by the Engineering and Physical Sciences ... of the UK,s vital industrial control systems which ... electricity grid, and the rail network. , ... from hackers or malware infiltrating the systems behind ... Institute in Trustworthy Industrial Control Systems (RITICS), based ...
(Date:10/1/2014)... 01, 2014 Marriagelifeinsurance.com has released ... insurance for retired couples. , Senior citizens can ... security for their loved ones. A joint policy is ... persons pass away. , Life insurance can be ... insurance can even be purchased online, as the application ...
(Date:10/1/2014)... October 01, 2014 Phoseon Technology, the ... continues to expand the business worldwide. This rapid growth ... additional capacity for manufacturing efforts. The company has experienced ... five years and expects this growth to continue in ... technology gains worldwide adoption. , “We are very ...
(Date:10/1/2014)... Beverly Hills, California (PRWEB) October 01, 2014 ... relationship expert, Dr. Kathleen Mojas is celebrating 20 years ... she has assisted hundreds of people to achieve greater ... released an important list of warning signs and suggestions ... relationship. , Dr. Mojas explains: “Believe it or ...
Breaking Medicine News(10 mins):Health News:Predicting the future course of psychotic illness 2Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3
... eye mainly during the surgical treatment of retinal hemorrhages or ... the detached retina to the wall of the eye. There ... during airplane travel, at high altitudes, or under nitrous oxide ... risk remains present for weeks after the surgical procedure. , ...
... ATLANTA, Feb. 25 CIBER, Inc. ... and implemented a service-oriented,architecture (SOA)-based software application ... for Disease Control and Prevention (CDC). CDCAS,reliably, ... and public,health organizations of disease outbreaks, bioterrorism ...
... small-diameter implants expanded more than 30% in 2007, ... according to Millennium Research Group, ... shows that small-diameter (less than or equal to 3.0 mm),dental ... implants are growing at a faster rate than those of ...
... Park have discovered that Normal Human Bronchial Epithelial (NHBE) ... the high end of plasma zinc attainable by oral ... arrest and DNA damage-induced gene (Gadd45) mRNA and protein ... research, published in the March 08 issue of the ...
... February 24, 2008: With a deep understanding of healthcare ... a global medical publisher, Elsevier is broadening its efforts ... (CDS) tools that help providers make optimal decisions at ... acquired CPM Resource Center, a provider of interactive nursing ...
... who examined blood test records in a survey of over ... found thousands of cases of probable undiagnosed diabetes. This could ... in UK. , The research is published in the ... was led by Dr Tim Holt of the University of ...
Cached Medicine News:Health News:CDC Uses CIBER-Built Solution to Alert Public Health Officials and Public Health Departments 2Health News:CDC Uses CIBER-Built Solution to Alert Public Health Officials and Public Health Departments 3Health News:CDC Uses CIBER-Built Solution to Alert Public Health Officials and Public Health Departments 4Health News:Small-Diameter Dental Implants Increasingly Popular In the US 2Health News:High zinc status in lung cells slows growth and induces DNA damage-induced gene expression 2Health News:High zinc status in lung cells slows growth and induces DNA damage-induced gene expression 3Health News:Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions 2Health News:Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions 3Health News:Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions 4Health News:GP's databases could identify tens of thousands with undiagnosed diabetes in UK 2
The Vitatron Excellence S+ lead series are endocardial leads providing excellent reliability and optimal pacing characteristics....
CapSure SP Novus endocardial, tined pacing leads provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but within an even smaller...
Bipolar Atrial "J" Lead...
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: